Administration of carnosine in the treatment of acute spinal cord injury
- 1 November 2011
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 82 (10), 1478-1489
- https://doi.org/10.1016/j.bcp.2011.07.074
Abstract
No abstract availableKeywords
Funding Information
- DCar (2008R23Z7K)
- MIUR (F5A3AF005)
- MIUR (FIRB RBRN07BMCT, RBNE08HWLZ001, I.N.B.B., “Fondi Ateneo”)
This publication has 57 references indexed in Scilit:
- Effects of Dietary Supplementation of Carnosine on Mitochondrial Dysfunction, Amyloid Pathology, and Cognitive Deficits in 3xTg-AD MicePLOS ONE, 2011
- Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative DisordersAntioxidants and Redox Signaling, 2010
- Resveratrol commonly displays hormesis: Occurrence and biomedical significanceHuman & Experimental Toxicology, 2010
- Carnosine protects against permanent cerebral ischemia in histidine decarboxylase knockout mice by reducing glutamate excitotoxicityFree Radical Biology & Medicine, 2010
- Increased oxidative-related mechanisms in the spinal cord injury in old ratsNeuroscience Letters, 2006
- Can cognitive deterioration associated with Down syndrome be reduced?Medical Hypotheses, 2005
- Anti-crosslinking properties of carnosine: Significance of histidineLife Sciences, 2004
- Oxidative Damage and Tyrosine Nitration from PeroxynitriteChemical Research in Toxicology, 1996
- Update on the Pathophysiology and Pathology of Acute Spinal Cord InjuryBrain Pathology, 1995
- Synthesis of nitric oxide in CNS glial cellsTrends in Neurosciences, 1993